Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
Search
×
Cancer Tissue Gallery Cytokeratin 18
Path
Created with Sketch.
Go to Cytokeratin 18 Normal Tissue Gallery
Go back to Product Page
Breast cancer - Strong diffuse CK18 positivity in a breast cancer NST.
Breast cancer – Strong diffuse CK18 positivity in a breast cancer NST.
Cervical cancer - Adenocarcinoma of the cervix uteri with intense CK18 positivity.
Cervical cancer – Adenocarcinoma of the cervix uteri with intense CK18 positivity.
Colorectal cancer - Adenocarcinoma of the colon with strong CK18 immunostaining.
Colorectal cancer – Adenocarcinoma of the colon with strong CK18 immunostaining.
Head and neck cancer - CK 18 negative squamous cell carcinoma of the larynx. Normal glandular cells serve as a positive staining control.
Head and neck cancer – CK 18 negative squamous cell carcinoma of the larynx. Normal glandular cells serve as a positive staining control.
Kidney cancer - Strong CK18 immunostaining in chromophobe renal cell carcinoma.
Kidney cancer – Strong CK18 immunostaining in chromophobe renal cell carcinoma.
Ovarian cancer - Strong CK18 immunostaining in a high grade serous carcinoma of the ovary.
Ovarian cancer – Strong CK18 immunostaining in a high grade serous carcinoma of the ovary.
Sarcoma - Weak to moderate CK18 neo-expression in a sarcoma NOS.
Sarcoma – Weak to moderate CK18 neo-expression in a sarcoma NOS.
Stomach cancer - strong diffuse CK18 expression in an intestinal type stomach adenocarcinoma.
Stomach cancer – strong diffuse CK18 expression in an intestinal type stomach adenocarcinoma.
Testicular cancer - Yolk sac carcinoma with strong CK18 immunostaining.
Testicular cancer – Yolk sac carcinoma with strong CK18 immunostaining.
Urinary bladder cancer - Strong diffuse CK18 expression in a muscle-invasive urothelial carcinoma.
Urinary bladder cancer – Strong diffuse CK18 expression in a muscle-invasive urothelial carcinoma.
Urinary bladder cancer - Strong diffuse CK18 immunostaining in a (micropapillary) urothelial carcinoma.
Urinary bladder cancer – Strong diffuse CK18 immunostaining in a (micropapillary) urothelial carcinoma.
Vaginal cancer - Absence of CK18 immunostaining in a squamous cell carcinoma of the vagina.
Vaginal cancer – Absence of CK18 immunostaining in a squamous cell carcinoma of the vagina.